TA, C., LMT, d. S., A, N., GCL, C., M, A., LA, A., . . . J, H. (2026). Association between SGLT2 inhibitors and outcomes after heart transplant in patients with type 2 diabetes: A systematic review and meta-analysis. Heart failure reviews, 31(1), . https://doi.org/10.1007/s10741-026-10641-3
Chicago Style (17th ed.) CitationTA, Costa, de Sousa LMT, Nogueira A, Chagas GCL, Abreu M, Allen LA, Cornwell WK 3rd, and Harrington J. "Association Between SGLT2 Inhibitors and Outcomes After Heart Transplant in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis." Heart Failure Reviews 31, no. 1 (2026). https://doi.org/10.1007/s10741-026-10641-3.
MLA (9th ed.) CitationTA, Costa, et al. "Association Between SGLT2 Inhibitors and Outcomes After Heart Transplant in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis." Heart Failure Reviews, vol. 31, no. 1, 2026, https://doi.org/10.1007/s10741-026-10641-3.